Eagle Point Credit Company, Cato Corporation, Another 5 Companies Have A High Estimated Dividend Yield

(VIANEWS) – Eagle Point Credit Company (ECC), Cato Corporation (CATO), Voya Global Equity Dividend and Premium Opportunity Fund (IGD) have the highest dividend yield stocks on this list.

Financial Asset Forward Dividend Yield Updated (EST)
Eagle Point Credit Company (ECC) 19.75% 2024-09-30 03:14:05
Cato Corporation (CATO) 12.88% 2024-09-29 11:15:05
Voya Global Equity Dividend and Premium Opportunity Fund (IGD) 10.64% 2024-10-01 05:11:05
AGNC Investment Corp. (AGNCM) 10.12% 2024-10-10 15:12:05
Blackrock Muni Intermediate Duration Fund (MUI) 5.23% 2024-10-02 01:41:05
Amgen (AMGN) 2.82% 2024-10-06 03:08:23
CME Group (CME) 2.05% 2024-10-06 03:08:52

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Eagle Point Credit Company (ECC) – Dividend Yield: 19.75%

Eagle Point Credit Company’s last close was $9.72, 7.34% under its 52-week high of $10.49. Intraday change was -0.31%.

Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.

Earnings Per Share

As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.71.

PE Ratio

Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 5.68. Meaning, the purchaser of the share is investing $5.68 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.45%.

Yearly Top and Bottom Value

Eagle Point Credit Company’s stock is valued at $9.72 at 10:15 EST, below its 52-week high of $10.49 and way above its 52-week low of $8.60.

More news about Eagle Point Credit Company.

2. Cato Corporation (CATO) – Dividend Yield: 12.88%

Cato Corporation’s last close was $5.28, 32.31% below its 52-week high of $7.80. Intraday change was 12.1%.

The Cato Corporation, together with its subsidiaries, operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. It operates through two segments, Retail and Credit. The company's stores and e-commerce Websites offer a range of apparel and accessories, including dressy, career, and casual sportswear; and dresses, coats, shoes, lingerie, costume jewelry, and handbags, as well as men's wear, and lines for kids and infants. It operates its stores and e-commerce Websites under the Cato, Cato Fashions, Cato Plus, It's Fashion, It's Fashion Metro, and Versona names. As of January 30, 2021, the company operated 1,330 stores in 33 states. It also provides credit card services to its customers, as well as layaway plans for customers who agree to make periodic payments. The company was incorporated in 1946 and is headquartered in Charlotte, North Carolina.

Earnings Per Share

As for profitability, Cato Corporation has a trailing twelve months EPS of $-0.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.76%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7.8%, now sitting on 678.87M for the twelve trailing months.

Yearly Top and Bottom Value

Cato Corporation’s stock is valued at $5.28 at 10:15 EST, way below its 52-week high of $7.80 and way above its 52-week low of $4.27.

More news about Cato Corporation.

3. Voya Global Equity Dividend and Premium Opportunity Fund (IGD) – Dividend Yield: 10.64%

Voya Global Equity Dividend and Premium Opportunity Fund’s last close was $5.64, 1.05% under its 52-week high of $5.70. Intraday change was 0.71%.

Voya Global Equity Dividend and Premium Opportunity Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC and NNIP Advisors B.V. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying stocks of companies having a market capitalization of $1 billion or more. The fund also invests through call options on selected indices, individual securities, and/or exchange traded funds. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index and the Chicago Board Options Exchange BuyWrite Monthly Index. It was formerly known as ING Global Equity Dividend and Premium Opportunity Fund. Voya Global Equity Dividend and Premium Opportunity Fund was formed on March 28, 2005 and is domiciled in the United States.

Earnings Per Share

As for profitability, Voya Global Equity Dividend and Premium Opportunity Fund has a trailing twelve months EPS of $0.4.

PE Ratio

Voya Global Equity Dividend and Premium Opportunity Fund has a trailing twelve months price to earnings ratio of 14.1. Meaning, the purchaser of the share is investing $14.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.48%.

Moving Average

Voya Global Equity Dividend and Premium Opportunity Fund’s worth is above its 50-day moving average of $5.56 and above its 200-day moving average of $5.23.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.4%, now sitting on 17.09M for the twelve trailing months.

Volume

Today’s last reported volume for Voya Global Equity Dividend and Premium Opportunity Fund is 343120 which is 21.71% above its average volume of 281901.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 1, 2024, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 10.64%.

More news about Voya Global Equity Dividend and Premium Opportunity Fund.

4. AGNC Investment Corp. (AGNCM) – Dividend Yield: 10.12%

AGNC Investment Corp.’s last close was $25.02, 3.21% below its 52-week high of $25.85. Intraday change was -0.16%.

AGNC Investment Corp. provides private capital to housing market in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016. AGNC Investment Corp. was incorporated in 2008 and is headquartered in Bethesda, Maryland.

Earnings Per Share

As for profitability, AGNC Investment Corp. has a trailing twelve months EPS of $-1.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.

Volatility

AGNC Investment Corp.’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.11%, a negative 0.05%, and a positive 0.30%.

AGNC Investment Corp.’s highest amplitude of average volatility was 0.16% (last week), 0.31% (last month), and 0.30% (last quarter).

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 1, 2024, the estimated forward annual dividend rate is 2.52 and the estimated forward annual dividend yield is 10.12%.

More news about AGNC Investment Corp..

5. Blackrock Muni Intermediate Duration Fund (MUI) – Dividend Yield: 5.23%

Blackrock Muni Intermediate Duration Fund’s last close was $12.62, 0.24% below its 52-week high of $12.65. Intraday change was 0.32%.

BlackRock Muni Intermediate Duration Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets. It primarily invests in investment grade municipal bonds exempt from federal income taxes and with a duration of three to ten years at the time of investment. BlackRock Muni Intermediate Duration Fund, Inc. was formed on August 1, 2003 and is domiciled in United States.

Earnings Per Share

As for profitability, Blackrock Muni Intermediate Duration Fund has a trailing twelve months EPS of $0.4.

PE Ratio

Blackrock Muni Intermediate Duration Fund has a trailing twelve months price to earnings ratio of 31.55. Meaning, the purchaser of the share is investing $31.55 for every dollar of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.8%, now sitting on 68.1M for the twelve trailing months.

Yearly Top and Bottom Value

Blackrock Muni Intermediate Duration Fund’s stock is valued at $12.62 at 10:15 EST, under its 52-week high of $12.65 and way higher than its 52-week low of $9.73.

More news about Blackrock Muni Intermediate Duration Fund.

6. Amgen (AMGN) – Dividend Yield: 2.82%

Amgen’s last close was $321.01, 7.45% below its 52-week high of $346.85. Intraday change was -1.01%.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Earnings Per Share

As for profitability, Amgen has a trailing twelve months EPS of $12.48.

PE Ratio

Amgen has a trailing twelve months price to earnings ratio of 21.42. Meaning, the purchaser of the share is investing $21.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.27%.

Sales Growth

Amgen’s sales growth is 23.5% for the present quarter and 15.9% for the next.

Volatility

Amgen’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.29%, a negative 0.12%, and a positive 1.00%.

Amgen’s highest amplitude of average volatility was 0.75% (last week), 0.96% (last month), and 1.00% (last quarter).

Volume

Today’s last reported volume for Amgen is 1865240 which is 36.92% below its average volume of 2957370.

More news about Amgen.

7. CME Group (CME) – Dividend Yield: 2.05%

CME Group’s last close was $221.25, 2.44% under its 52-week high of $226.78. Intraday change was -1.54%.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

Earnings Per Share

As for profitability, CME Group has a trailing twelve months EPS of $8.85.

PE Ratio

CME Group has a trailing twelve months price to earnings ratio of 23.67. Meaning, the purchaser of the share is investing $23.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.91%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CME Group’s stock is considered to be overbought (>=80).

Moving Average

CME Group’s worth is under its 50-day moving average of $211.87 and above its 200-day moving average of $208.35.

Volatility

CME Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.45%, a positive 0.07%, and a positive 0.81%.

CME Group’s highest amplitude of average volatility was 0.45% (last week), 0.64% (last month), and 0.81% (last quarter).

More news about CME Group.

Leave a Reply

Your email address will not be published. Required fields are marked *